Antiretroviral Theraphy: towards 2000

Abstract

Antiretroviral theraphy is now approaching its 10-year anniversary. Zidovudine and other nucleoside analogues have been the cornerstone of this theraphy until recently. Now, protease inhibitors are the most promising agents and the antiretroviral theraphy in 2000s will be based on combinations of inhibitors of both reverse transcriptase and viral protease